Governance Celltrion, Inc.

A068270

KR7068270008

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 2025-12-16			5-day change	1st Jan Change
185,600.00 ^KRW	-1.17%		-0.80%	+2.95%

Dec. 10	Celltrion USA, Inc. announced that it expects to receive $532.1 million in funding from Celltrion, Inc.	CI
Dec. 10	Celltrion, Inc. announces Annual dividend	CI

Executive Committee: Celltrion, Inc.

Manager

Positions heldSince

Wu-Sung Ki

Chief Executive Officer

2015-03-19

Ho-Seop Lee

50 year

Director of Finance/CFO

Sung-Han Lee

43 year

Compliance Officer	-
General Counsel	-

Composition of the Board of Directors: Celltrion, Inc.

Director

CommitteesSince

Jung-Jin Seo

68 year

Nominating Committee

Joseph Lee

67 year

Audit Committee Chair

2008-07-16

Gyun-Seok Cho

66 year

Audit Committee

2009-03-19

Jong-Seok Lee

73 year

Audit Committee

2014-12-07

Dong-Il Kim

67 year

Audit Committee

2008-07-16

Wu-Sung Ki

Director/Board Member

2007-04-23

Byung-Hoon Jeon

68 year

Director/Board Member	2014-03-26
Independent Dir/Board Member	2014-03-26

Geun-Young Kim

65 year

Director/Board Member
Independent Dir/Board Member

Dae-Hyeon Yoo

67 year

Director/Board Member
Independent Dir/Board Member

Soon-Woo Lee

75 year

Director/Board Member
Independent Dir/Board Member

Jae-Sik Lee

67 year

Director/Board Member
Independent Dir/Board Member

Min-Cheol Shin

62 year

Director/Board Member

Hyeok-Jae Lee

50 year

Director/Board Member

Young-Hye Ko

70 year

Director/Board Member
Independent Dir/Board Member

Latest Appointments: Celltrion, Inc.

23-03-07

Celltrion Group Creator Expected to Resume Leadership Role

More news

Former Officers and Directors: Celltrion, Inc.

Insider

Positions held

SinceUntil

Won-Seok Kim

Director/Board Member	-	2022-03-31
Independent Dir/Board Member	-	2022-03-31

Hong-Hee Cho

Director/Board Member	2013-03-21	-
Independent Dir/Board Member	2013-03-21	-

Zheru Zhang

Chief Tech/Sci/R&D Officer

2008-02-29

2012-09-30

Jin-Kyu Wang

Corporate Officer/Principal

2011-06-01

2012-04-29

Brian Byeoung Kim

Corporate Officer/Principal

2011-05-31

2012-04-29

Daniel P. Slone

Corporate Officer/Principal

2011-05-31

John S. Kim

Corporate Officer/Principal

2011-06-01

Hans-Peter Hasler

Director/Board Member	2011-05-31	-
Independent Dir/Board Member	2011-05-31	-

Gyung-Ho Lee

Director/Board Member

2008-07-16

James Panek

Chief Executive Officer	2001-12-31	2005-12-31
Chairman	2001-12-31	2005-12-31

Hyung-Ki Kim

Director/Board Member	2005-03-31	-
Chief Executive Officer	2015-03-19	-
Corporate Officer/Principal	2005-03-31	-

Jae Chung

Founder	-	-
Corporate Officer/Principal	-	-

Alex Kudrin

Corporate Officer/Principal

Elizabeth Pollitt

Corporate Officer/Principal

Serge S. Laveault

Corporate Officer/Principal

Dong-Gyu Ji

Corporate Officer/Principal

Gail M. Ward

Corporate Officer/Principal

Sung-Do Park

Corporate Officer/Principal

2011-06-01

Hong-Seok Cho

Corporate Officer/Principal

2011-06-01

Yun-Sook Jang

Corporate Officer/Principal

2011-06-01

Jae-Hyeon Kim

Corporate Officer/Principal

2011-06-01

Ho-Eun Yoo

Corporate Officer/Principal

2011-06-01

In-Kyu Kim

Corporate Officer/Principal

2011-05-31

Seung-Seo Hong

Chief Tech/Sci/R&D Officer

2011-05-31

Hee-Choon Yang

Corporate Officer/Principal

2011-05-31

Yong-Jik Kim

Corporate Officer/Principal

2011-05-31

Min-Young Soh

Corporate Officer/Principal

2011-05-31

Kwang-Ho Kim

Corporate Officer/Principal

2011-05-31

Geun-Kyung Lee

Corporate Officer/Principal

2011-05-31

Myung-Geun Oh

Chief Operating Officer	-	-
Corporate Officer/Principal	-	-

Ik-Sung Ahn

Corporate Officer/Principal

2011-06-01

Gang-Heui Cho

Corporate Officer/Principal

Young-Deok Gwon

Corporate Officer/Principal

Seung-Heon Nam

Corporate Officer/Principal

2011-05-31

Je-Roo Jang

Corporate Officer/Principal

2011-06-01

Bok-Jong Hyun

Corporate Officer/Principal

2011-06-01

Young-Seon Kwon

Corporate Officer/Principal

2011-06-01

Jeong-Su Seo

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	20
Female	0

Of which Executive Committee

Male	3
Female	0

Of which Directors

Male	14
Female	0

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.

Employees

2,680

Sector

Biotechnology & Medical Research

Calendar

Mar. 03 - Q4 2025 Earnings Release (Projected)

More about the company